James H. Fergus - Concepedia

Concepedia

Author

James H. Fergus

Time Warner (United States)

Also Known As

J H Fergus, J. FERGUS, J. Fergus, J. H. FERGUS, J.H. Fergus, James Fergus, James H. Fergus

19

Publications

1.4K

Citations

12

H-Index

31

Concepts

All Affiliations

Time Warner (United States)

JH

About

James H. Fergus is an author at Time Warner (United States) specializing in biochemistry, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	871
2	Biochemistry	6	6	832
3	Natural Sciences	4	4	426
4	Engineering	1	1	60
5	Social Sciences	1	1	377

James H. Fergus

×

12

Publications

1.4K

Citations

12

H-Index

	Year	Citations
Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes Robert F. Bruns, James H. Fergus, Edward W. Badger, Naunyn-Schmiedeberg s Archives of Pharmacology BiochemistryNeurophysiologyMedicineNeuropeptide ReceptorNeuropharmacology	1987	377
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901 Stephen D. Barrett, Alexander J. Bridges, David T. Dudley, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDrug TargetBiochemistryNatural SciencesMedicine	2008	280
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes. Robert F. Bruns, James H. Fergus Molecular Pharmacology	1990	250
Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes. Robert F. Bruns, James H. Fergus, Linda L. Coughenour, Molecular Pharmacology	1990	105
PD 115,199: An antagonist ligand for adenosine A2 receptors Robert F. Bruns, James H. Fergus, Edward W. Badger, Naunyn-Schmiedeberg s Archives of Pharmacology Signal TransductionG Protein-coupled ReceptorAdenosine A2 ReceptorsMedicineFunctional Selectivity	1987	98
Structure-Based Design of a Novel Series of Nonpeptide Ligands That Bind to the pp60<sup>src</sup> SH2 Domain Elizabeth A. Lunney, Kimberly S. Para, John R. Rubin, Journal of the American Chemical Society EngineeringNonpeptide LigandsMolecular BiologyChemistrySh2 Domain	1997	60
Design, Synthesis, and Cocrystal Structure of a Nonpeptide Src SH2 Domain Ligand Mark S. Plummer, Debra R. Holland, Aurash Shahripour, Journal of Medicinal Chemistry	1997	48
The Role of 4-phosphonodifluoromethyl- and 4-phosphono-phenylalanine in the selectivity and cellular uptake of SH2 domain ligands Charles J. Stankovic, Narayanan Surendran, Elizabeth A. Lunney, Bioorganic & Medicinal Chemistry Letters Proteinlipid InteractionBiochemistryNatural SciencesCellular UptakeMedicine	1997	45
Solubilities of Adenosine Antagonists Determined by Radioreceptor Assay Robert F. Bruns, James H. Fergus Journal of Pharmacy and Pharmacology Molecular PharmacologyMedicinal ChemistryAdenosine Receptor AffinitySolubility/affinity RatiosBiochemistry	1989	41
Design of peptidomimetic ligands for the pp60src SH2 domain Mark S. Plummer, Elizabeth A. Lunney, Kimberly S. Para, Bioorganic & Medicinal Chemistry Molecular ComplexPeptoidPp60src Sh2 DomainBiomolecular Engineering	1997	31

Page 1